Literature DB >> 30118823

The opioid system in stress-induced memory disorders: From basic mechanisms to clinical implications in post-traumatic stress disorder and Alzheimer's disease.

Angélica Torres-Berrio1, Mauricio O Nava-Mesa2.   

Abstract

Cognitive and emotional impairment are a serious consequence of stress exposure and are core features of neurological and psychiatric conditions that involve memory disorders. Indeed, acute and chronic stress are high-risk factors for the onset of post-traumatic stress disorder (PTSD) and Alzheimer's disease (AD), two devastating brain disorders associated with memory dysfunction. Besides the sympathetic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis, stress response also involves the activation of the opioid system in brain regions associated with stress regulation and memory processing. In this context, it is possible that stress-induced memory disorders may be attributed to alterations in the interaction between the neuroendocrine stress system and the opioid system. In this review, we: (1) describe the effects of acute and chronic stress on memory, and the modulatory role of the opioid system, (2) discuss the contribution of the opioid system to the pathophysiology of PTSD and AD, and (3) present evidence of current and potential therapies that target the opioid receptors to treat PTSD- and AD-associated symptoms.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Memory; Neuropsychiatric stress disorders; Opioid System; Stress

Mesh:

Substances:

Year:  2018        PMID: 30118823     DOI: 10.1016/j.pnpbp.2018.08.011

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

Review 1.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

2.  The authors respond to "Fentanyl patch probably not related to amnesia in case".

Authors:  Ryan G Taylor; Seyed M Mirsattari; Donald H Lee
Journal:  CMAJ       Date:  2019-11-04       Impact factor: 8.262

Review 3.  The Reward System and Post-Traumatic Stress Disorder: Does Trauma Affect the Way We Interact With Positive Stimuli?

Authors:  Rebecca Seidemann; Or Duek; Ruonan Jia; Ifat Levy; Ilan Harpaz-Rotem
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-02-25

Review 4.  Bacomics: a comprehensive cross area originating in the studies of various brain-apparatus conversations.

Authors:  Dezhong Yao; Yangsong Zhang; Tiejun Liu; Peng Xu; Diankun Gong; Jing Lu; Yang Xia; Cheng Luo; Daqing Guo; Li Dong; Yongxiu Lai; Ke Chen; Jianfu Li
Journal:  Cogn Neurodyn       Date:  2020-03-17       Impact factor: 3.473

5.  Rate and correlates of post-traumatic stress disorder (PTSD) following the Beirut blast and the economic crisis among Lebanese University students: a cross-sectional study.

Authors:  Christian-Joseph El Zouki; Abdallah Chahine; Mariam Mhanna; Sahar Obeid; Souheil Hallit
Journal:  BMC Psychiatry       Date:  2022-08-05       Impact factor: 4.144

Review 6.  Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection.

Authors:  Gloria Ortiz-Guerrero; Rodrigo E Gonzalez-Reyes; Alejandra de-la-Torre; German Medina-Rincón; Mauricio O Nava-Mesa
Journal:  Brain Sci       Date:  2020-06-12

7.  GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats.

Authors:  Zhen Wei; Yacoubou Abdoul Razak Mahaman; Feiqi Zhu; Mengjuan Wu; Yiyuan Xia; Kuan Zeng; Ying Yang; Rong Liu; Jian-Zhi Wang; Xiji Shu; Xiaochuan Wang
Journal:  Aging (Albany NY)       Date:  2019-09-23       Impact factor: 5.682

8.  Polymorphisms of stress pathway genes and emergence of suicidal ideation at antidepressant treatment onset.

Authors:  B Nobile; N Ramoz; I Jaussent; J Dubois; S Guillaume; Ph Gorwood; Ph Courtet
Journal:  Transl Psychiatry       Date:  2020-09-20       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.